Clinical trial
Evaluation of the Performance of Panuri - Test for Detection of Pancreatic Ductal Adenocarcinoma
NCT07587866 is registered in ClinicalTrials.gov with Urteste S.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Performance of Panuri - Test for Detection of Pancreatic Ductal Adenocarcinoma
- Lead sponsor
- Urteste S.A
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 10, 2026
- Completion date
- January 31, 2028
- Enrollment
- 1,100 (estimated)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic ductal adenocarcinoma (pdac)